at Nasdaq.com (Fri, 12:21PM)
Acadia Pharmaceuticals (ACAD) continues to soar, now up over 27% after saying its drug candidate...
Acadia Pharmaceuticals (ACAD) continues to soar, now up over 27% after saying its drug candidate Pimavanserin worked very well reducing hallucinations and delusions related to Parkinson's Disease during Phase III testing.
From other sites
at Benzinga.com (Jan 12, 2015)
at CNBC.com (Dec 12, 2014)
at Nasdaq.com (Nov 17, 2014)
at CNBC.com (Nov 4, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs